Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections
A Phase IV, Multicenter, Prospective, Randomized, Controlled Clinical Study to Compare the Irrisept System Versus Standard of Care (SoC) on the Prevalence of Surgical Site Infections in Patients With Abdominal Trauma or Acute Surgical Abdomen
Sponsor: Irrimax Corporation
Terminated
The study was terminated early after the Interim Analysis due, in part, to issues with the accuracy and completeness of the data collected.
Other terminated trials from Irrimax Corporation
More terminations from Irrimax Corporation
Other Surgical Site Infection trials with similar outcome
This NA trial investigates Surgical Site Infection and is currently terminated or withdrawn. Irrimax Corporation leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2022 — Jul 2024 [monthly]
Terminated NA
Status: Completed → Terminated · Phase: PHASE4 → NA
-
Jan 2021 — Jun 2022 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Suspended → Completed
-
Jul 2017 — Aug 2017 [monthly]
Suspended PHASE4
Status: Recruiting → Suspended
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Irrimax Corporation
For direct contact, visit the study record on ClinicalTrials.gov .